Doseloop Beta

Paroxetine

medication Under review

A selective serotonin reuptake inhibitor (SSRI) antidepressant used to treat depression, anxiety, and other mental health conditions.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from randomized controlled trials and meta-analyses primarily demonstrates paroxetine's modest efficacy over placebo in reducing symptoms of anxiety and depression, with effect sizes indicating clinical benefits in responder rates and symptom score improvements. However, overall treatment acceptability is limited by higher dropout rates due to adverse events, and superiority to placebo is not consistently observed across all outcomes in acute treatment settings. Research consensus highlights its role in psychiatric applications but notes challenges with tolerability and lack of clear advantages in healthy populations without disorders.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (4 studies)

Meta-Analysis

The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression

PLOS ONE • 2014 • n=8571

Multiple authors (meta-analysis)

RCT

Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Social Anxiety Disorder

ClinicalTrials.gov • 2009 • n=528

Not specified in record

Meta-Analysis

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.

CMAJ • 2007 • n=6391

Undurraga J, Baldessarini RJ

RCT

Paroxetine Clinical BPCA

FDA • 2002 • n=700

FDA Review Team

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 3
Side effects noted 3